Tiziana Life Sciences Ltd
TLSA
$2.04
-$0.09-4.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.01% | -21.01% | 20.55% | 20.55% | 45.99% |
| Total Depreciation and Amortization | 41.94% | 41.94% | 51.22% | 51.22% | 12.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.39% | -87.39% | 565.21% | 565.21% | 40.29% |
| Change in Net Operating Assets | -200.71% | -200.71% | -162.01% | -162.01% | 132.46% |
| Cash from Operations | -1,805.75% | -1,805.75% | 55.27% | 55.27% | 103.51% |
| Capital Expenditure | 57.14% | 57.14% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 20,671.43% | 20,671.43% | 99.50% | 99.50% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 30.43% | 30.43% | 12.20% | 12.20% | -86.49% |
| Issuance of Common Stock | -- | -- | 18,484.00% | 18,484.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10,766.67% | 10,766.67% | 5,697.44% | 5,697.44% | 76.29% |
| Foreign Exchange rate Adjustments | 129.73% | 129.73% | 101.61% | 101.61% | -334.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6,754.72% | 6,754.72% | 147.91% | 147.91% | 99.54% |